Trial Profile
Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary) ; Atenolol
- Indications Diabetic angiopathies; Diabetic nephropathies; Hypertension
- Focus Pharmacodynamics
- Acronyms IREDIS
- Sponsors Sanofi
- 06 Nov 2007 New trial record.